Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

Apr 30, 2007

34519_dirs_2007-04-30_b2e230ea-9c6b-4e25-a518-0003c38719d0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-04-26

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-04-26 Common Stock, par value $0.10 per share P 100 $5.79 Acquired 389917 Direct
2007-04-26 Common Stock, par value $0.10 per share P 1800 $5.80 Acquired 391717 Direct
2007-04-26 Common Stock, par value $0.10 per share P 400 $5.81 Acquired 392117 Direct
2007-04-26 Common Stock, par value $0.10 per share P 400 $5.70 Acquired 392517 Direct
2007-04-27 Common Stock, par value $0.10 per share P 1000 $5.70 Acquired 393517 Direct
2007-04-27 Common Stock, par value $0.10 per share P 200 $5.68 Acquired 393717 Direct
2007-04-27 Common Stock, par value $0.10 per share P 150 $5.69 Acquired 393867 Direct
2007-04-30 Common Stock, par value $0.10 per share P 100 $5.67 Acquired 393967 Direct
2007-04-30 Common Stock, par value $0.10 per share P 100 $5.7 Acquired 394067 Direct
2007-04-30 Common Stock, par value $0.10 per share P 200 $5.7 Acquired 394267 Direct

Footnotes

F1: These shares of common stock were acquired by Arterio, Inc., a corporation owned solely by Mr. Rothschild.

F2: This figure includes 197,150 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.